Cvrx Share Price (NASDAQ: CVRX)

$7.85

▲

-0.03

(-0.38%)

Last updated on August 30, 2025 at 1:29 am IST

$₹

Check the interactive Cvrx Stock chart to analyse performance

Cvrx stock performance

as on August 30, 2025 at 1:29 am IST

Today's Low:$7.65
Today's High:$8.00
$7.85
2.55%
Downside
Day's Volatility :4.37%
Upside
1.88%
52 Weeks Low:$4.30
52 Weeks High:$18.55
$7.85
45.23%
Downside
52 Weeks Volatility :76.82%
Upside
57.68%

Cvrx Stock Returns

Period	Cvrx Inc	Sector (Health Care)	Index (Russel 2000)
3 Months	20.83%	3.6%	0.0%
6 Months	-36.6%	-7.7%	0.0%
1 Year	-13.48%	-12.6%	0.0%
3 Years	8.6%	9.5%	-4.7%

Cvrx Inc Key Stats

Check Cvrx key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close	$7.88
Open	$8.0
Today's High	$8.0
Today's Low	$7.65
Market Capitalization	$206.1M
Today's Volume	$117.0K
52 Week High	$18.55
52 Week Low	$4.2993
Revenue TTM	$54.7M
EBITDA	$-50.4M
Earnings Per Share (EPS)	$-2.06
Profit Margin	-95.61%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-92.33%

Stock Returns calculator for Cvrx Stock including INR - Dollar returns

The Cvrx stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Cvrx investment value today

Current value as on today

₹84,899

Returns

₹15,101

(-15.1%)

Returns from Cvrx Stock

₹20,385 (-20.39%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Cvrx Stock

-38%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Cvrx Stock from India on INDmoney has decreased by -38% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Cvrx Inc

Name
Holdings %
Name
Holdings %
Johnson & Johnson
15.69%
NEA Management Company, LLC
7.75%
Vanguard Group Inc
4.12%
BlackRock Inc
3.85%
Parkman Healthcare Partners LLC
3.02%
Balyasny Asset Management LLC
1.56%

Analyst Recommendation on Cvrx Stock

Rating

Trend

Buy

91%Buy

8%Hold

0%Sell

Based on 12 Wall street analysts offering stock ratings for Cvrx(by analysts ranked 0 to 5 stars)

Cvrx Share Price Target

What analysts predicted

Upside of 38.0%

Target:

$10.83

Current:

$7.85

Cvrx share price target is $10.83, a slight Upside of 38.0% compared to current price of $7.85 as per analysts' prediction.

Cvrx Stock Insights

Price Movement
In the last 6 months, CVRX stock has moved down by -39.6%
Increasing Revenue
Revenue is up for the last 2 quarters, 12.34M → 13.58M (in $), with an average increase of 9.1% per quarter
Decreasing Net Profit
Netprofit is down for the last 3 quarters, -10.65M → -14.73M (in $), with an average decrease of 18.2% per quarter
CVRX vs BSX (1 yr)
In the last 1 year, Boston Scientific Corp. has given 29.0% return, outperforming this stock by 49.6%
CVRX vs BSX (3 yr)
In the last 3 years, Boston Scientific Corp. has given 163.5% return, outperforming this stock by 158.7%
Price to Sales
ForCVRX every $1 of sales, investors are willing to pay $3.6, whereas for Boston Scientific Corp., the investors are paying $8.4 for every $1 of sales.

Cvrx Inc Financials

Revenue

Profit

Cash Flow

Annually

Quarterly

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Revenue	$6.3M	-
Net Income	$-14.6M	-
Net Profit Margin	-233.87%	-

	FY20	Y/Y Change
Revenue	$6.1M	↓ 3.26%
Net Income	$-14.1M	↓ 3.58%
Net Profit Margin	-233.09%	↑ 0.78%

	FY21	Y/Y Change
Revenue	$13.0M	↑ 115.36%
Net Income	$-43.1M	↑ 205.32%
Net Profit Margin	-330.45%	↓ 97.36%

	FY22	Y/Y Change
Revenue	$22.5M	↑ 72.36%
Net Income	$-41.4M	↓ 3.83%
Net Profit Margin	-184.38%	↑ 146.07%

	FY23	Y/Y Change
Revenue	$39.3M	↑ 74.89%
Net Income	$-41.2M	↓ 0.55%
Net Profit Margin	-104.85%	↑ 79.53%

	FY24	Y/Y Change
Revenue	$51.3M	↑ 30.53%
Net Income	$-60.0M	↑ 45.55%
Net Profit Margin	-116.91%	↓ 12.06%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Revenue	$10.8M	↓ 4.73%
Net Income	$-22.2M	↑ 142.13%
Net Profit Margin	-206.0%	↓ 124.95%

	Q2 FY24	Q/Q Change
Revenue	$11.8M	↑ 9.63%
Net Income	$-14.0M	↓ 36.77%
Net Profit Margin	-118.82%	↑ 87.18%

	Q3 FY24	Q/Q Change
Revenue	$13.4M	↑ 13.26%
Net Income	$-13.1M	↓ 6.63%
Net Profit Margin	-97.95%	↑ 20.87%

	Q4 FY24	Q/Q Change
Revenue	$15.3M	↑ 14.72%
Net Income	$-10.7M	↓ 18.69%
Net Profit Margin	-69.42%	↑ 28.53%

	Q1 FY25	Q/Q Change
Revenue	$12.3M	↓ 19.52%
Net Income	$-13.8M	↑ 29.25%
Net Profit Margin	-111.48%	↓ 42.06%

	Q2 FY25	Q/Q Change
Revenue	$13.6M	↑ 10.05%
Net Income	$-14.7M	↑ 7.05%
Net Profit Margin	-108.44%	↑ 3.04%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Profit	$4.6M	-

	FY20	Y/Y Change
Profit	$4.6M	↑ 0.85%

	FY21	Y/Y Change
Profit	$9.4M	↑ 103.69%

	FY22	Y/Y Change
Profit	$17.5M	↑ 85.93%

	FY23	Y/Y Change
Profit	$33.0M	↑ 89.12%

	FY24	Y/Y Change
Profit	$43.0M	↑ 30.02%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Profit	$9.0M	↓ 5.85%

	Q2 FY24	Q/Q Change
Profit	$9.8M	↑ 8.22%

	Q3 FY24	Q/Q Change
Profit	$11.1M	↑ 13.92%

	Q4 FY24	Q/Q Change
Profit	$13.0M	↑ 17.24%

	Q1 FY25	Q/Q Change
Profit	$10.3M	↓ 20.94%

	Q2 FY25	Q/Q Change
Profit	$11.5M	↑ 11.04%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Operating Cash Flow	$-12.8M	-
Investing Cash Flow	$-106.0K	-
Financing Cash Flow	$29.5M	-

	FY20	Y/Y Change
Operating Cash Flow	$-16.1M	↑ 25.9%
Investing Cash Flow	$-311.0K	↑ 193.4%
Financing Cash Flow	$49.8M	↑ 68.48%

	FY21	Y/Y Change
Operating Cash Flow	$-27.7M	↑ 72.29%
Investing Cash Flow	$-1.2M	↑ 280.39%
Financing Cash Flow	$111.9M	↑ 124.74%

	FY22	Y/Y Change
Operating Cash Flow	$-42.7M	↑ 53.89%
Investing Cash Flow	$-685.0K	↓ 42.1%
Financing Cash Flow	$7.5M	↓ 93.3%

	FY23	Y/Y Change
Operating Cash Flow	$-39.0M	↓ 8.57%
Investing Cash Flow	$-591.0K	↓ 13.72%
Financing Cash Flow	$24.0M	↑ 220.09%

	FY24	Y/Y Change
Operating Cash Flow	$-39.1M	↑ 0.32%
Investing Cash Flow	$-1.4M	↑ 130.29%
Financing Cash Flow	$55.9M	↑ 132.95%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Operating Cash Flow	$-10.9M	↑ 39.0%
Investing Cash Flow	$-917.0K	↑ 442.6%
Financing Cash Flow	$1.4M	↓ 91.26%

	Q2 FY24	Q/Q Change
Operating Cash Flow	$-9.8M	↓ 9.78%
Investing Cash Flow	$-355.0K	↓ 61.29%
Financing Cash Flow	$472.0K	↓ 65.35%

	Q3 FY24	Q/Q Change
Operating Cash Flow	$-10.4M	↑ 5.9%
Investing Cash Flow	$-37.0K	↓ 89.58%
Financing Cash Flow	$40.2M	↑ 8417.37%

	Q4 FY24	Q/Q Change
Operating Cash Flow	$-8.0M	↓ 23.07%
Investing Cash Flow	$-52.0K	↑ 40.54%
Financing Cash Flow	$13.8M	↓ 65.59%

	Q1 FY25	Q/Q Change
Operating Cash Flow	$-12.8M	↑ 59.43%
Investing Cash Flow	$-114.0K	↑ 119.23%
Financing Cash Flow	$9.6M	↓ 30.5%

	Q2 FY25	Q/Q Change
Operating Cash Flow	$-7.9M	↓ 37.84%
Investing Cash Flow	$-103.0K	↓ 9.65%
Financing Cash Flow	$392.0K	↓ 95.92%

Cvrx Technicals Summary

Sell

Neutral

Buy

Cvrx is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Cvrx Inc Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Cvrx Inc	-1.63%	-36.6%	-13.48%	8.6%	-57.77%
Medtronic Plc	3.87%	-1.59%	4.32%	4.82%	-13.69%
Edwards Lifesciences Corp.	2.55%	13.95%	18.33%	-9.73%	-5.31%
Boston Scientific Corp.	0.09%	0.6%	30.02%	157.38%	154.4%
Stryker Corporation	3.63%	-0.85%	8.87%	89.43%	97.71%
Abbott Laboratories	5.15%	-5.37%	15.72%	26.56%	24.53%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Cvrx Inc	0.14	NA	NA	-2.03	-0.92	-0.3	NA	2.22
Medtronic Plc	25.4	25.4	2.14	5.46	0.1	0.05	0.03	37.36
Edwards Lifesciences Corp.	34.03	34.03	4.85	2.5	0.16	0.08	NA	17.94
Boston Scientific Corp.	62.95	62.95	1.84	2.98	0.12	0.05	NA	15.14
Stryker Corporation	51.54	51.54	2.24	13.49	0.14	0.08	0.01	55.43
Abbott Laboratories	16.64	16.64	4.17	5.14	0.31	0.07	0.02	29.05

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Cvrx Inc	Buy	$206.1M	-57.77%	0.14	-95.61%
Medtronic Plc	Buy	$118.0B	-13.69%	25.4	13.63%
Edwards Lifesciences Corp.	Buy	$47.8B	-5.31%	34.03	72.96%
Boston Scientific Corp.	Buy	$156.7B	154.4%	62.95	13.55%
Stryker Corporation	Buy	$149.0B	97.71%	51.54	12.25%
Abbott Laboratories	Buy	$230.9B	24.53%	16.64	32.43%

About Cvrx Inc

CVRx, Inc., a commercial-stage medical device company, engages in developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases in the United States, Germany, and internationally. The company offers Barostim, a neuromodulation device that enhance symptoms for patients with heart failure by delivering electrical pulses to baroreceptors. It sells its products through direct sales force, sales agents, and independent distributors. The company was incorporated in 2000 and is headquartered in Minneapolis, Minnesota.

Organization	Cvrx
Employees	206
CEO	Mr. Kevin Hykes
Industry	Healthcare

Key Management of Cvrx Inc

Name	Title
Mr. Kevin Hykes	President, CEO & Director
Mr. Jared Oasheim	Chief Financial Officer
Mr. Robert Allen John	Chief Revenue Officer
Mr. Brent Binkowski	Chief Operating Officer
Ms. Jonelle R. Burnham	VP & General Counsel
Mr. Paul Verrastro	Chief Marketing & Strategy Officer
Ms. Tonya A. Austin SPHR	Chief Human Resources Officer
Dr. Philip B. Adamson M.D., M.Sc.	Chief Medical Officer
Ms. Bonnie Handke M.B.A., R.N.	Senior Vice President of Patient Access, Reimbursement, & Healthcare Economics

Important FAQs about investing in CVRX Stock from India :

What is Cvrx share price today?

Cvrx share price today is $7.85 as on August 30, 2025 at 1:29 am IST at the close of the market. Cvrx share today touched a day high of $8.00 and a low of $7.65.

What is the 52 week high and 52 week low for Cvrx share?

Cvrx share touched a 52 week high of $18.55 and a 52 week low of $4.30. Cvrx stock price today i.e. August 30, 2025 at 1:29 am IST is closed at $7.85, lower by 57.68% versus the 52 week high.

How to invest in Cvrx Stock (CVRX) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Cvrx on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Cvrx Shares that will get you 0.1911 shares as per Cvrx share price of $7.85 per share as on August 30, 2025 at 1:29 am IST.

What is the minimum amount required to buy Cvrx Stock (CVRX) from India?

Indian investors can start investing in Cvrx (CVRX) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Cvrx stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Cvrx share’s latest price of $7.85 as on August 30, 2025 at 1:29 am IST, you will get 1.2739 shares of Cvrx. Learn more about fractional shares .

What are the returns that Cvrx has given to Indian investors in the last 5 years?

Cvrx stock has given -57.77% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?